| Adaptimmune Ltd.. (9/30/19). "Press Release: Clear Benefit for Patients with Synovial Sarcoma Demonstrated in Updated Data from Ongoing Phase 1 Trial with ADP-A2M4 Presented at ESMO". Philadeliphia, PA & Oxfordshire. |
2019-09-30 |
| Innate Pharma S.A.. (9/23/19). "Press Release: Innate Pharma Announces Clinical Data Presentations on IPH5401 and Monalizumab at ESMO 2019". Marseille. |
2019-09-23 |
| CRISPR Therapeutics AG. (9/17/19). "Press Release: CRISPR Therapeutics and ViaCyte Present Positive In Vitro Data Towards a Potential Immune-Evasive Cell Replacement Therapy for Diabetes at EASD 2019". Zug, Cambridge, MA & San Diego, CA. |
2019-09-17 |
| Devicare S.L.. (9/5/19). "Press Release: The PREVENTLIT Study Shows that Lit-Control Reduces new Episodes of Renal Lithiasis in Patients". Cerdanyola del Vallès. |
2019-09-05 |
| Grifols S.A.. (7/31/19). "Press Release: Grifols Increases Its Revenues by 14.3% to EUR 2,423 million, Driven by Its Strategic Growth Plan". Barcelona. |
2019-07-31 |
| 3P Biopharmaceuticals S.L.. (7/23/19). "Press Release: 3P Biopharmaceuticals Welcomes Keensight Capital as Majority Shareholder". Paris. |
2019-07-23 |
| Keensight Capital. (7/23/19). "Press Release: Keensight Capital Acquires 3P Biopharmaceuticals to Accelerate Its Global Growth Strategy". Paris. |
2019-07-23 |
| ImCheck Therapeutics S.A.S.. (7/18/19). "Press Release: ImCheck Therapeutics Appoints Paul Frohna MD, PhD, PharmD, as Chief Medical Officer". Marseille. |
2019-07-18 |
| Arcis Biotechnology Ltd.. (7/16/19). "Press Release: Arcis Biotechnology and Mirnax Biosens Sign Exclusive License Agreement for Arcis Sample Prep Technology". Daresbury & Madrid. |
2019-07-16 |
| Laboratoris Sanifit S.L.. (6/26/19). "Press Release: Sanifit Announces €72.2M ($80.9M) Financing in Spain’s Largest Private Biotech Fundraise". Palma & San Diego, CA. |
2019-06-26 |
| Galapagos N.V.. (5/29/19). "Press Release: Gilead and Galapagos to Present Latest Data on Filgotinib at the Annual European Congress of Rheumatology (EULAR 2019)". Foster City, CA & Mechelen. |
2019-05-29 |
| Pfizer Inc.. (5/7/19). "Press Release: European Commission Approves Lorviqua (lorlatinib) for Certain Adult Patients with Previously-Treated ALK-Positive Advanced Non-Small Cell Lung Cancer". |
2019-05-07 |
| Devicare S.L.. (5/3/19). "Press Release: Devicare Launches Lit-Control in the US with Diem Labs". |
2019-05-03 |
| Sophia Genetics S.A.. (4/11/19). "Press Release: Sophia Genetics Achieves CE-IVD Milestone for Its Solid Tumor Solution for Accurate Cancer Detection". Lausanne. |
2019-04-11 |
| PharmaMar S.A.. (3/25/19). "Press Release: PharmaMar Announces Positive Results in Its Lurbinectedin Monotherapy Trial for Small Cell Lung Cancer". Madrid. |
2019-03-25 |
| Minoryx Therapeutics S.L.. (3/12/19). "Press Release: Minoryx Therapeutics Appoints Didier Le Normand as Group Chief Financial Officer (CFO) and General Manager of Its Belgian Subsidiary". Mataró, Barcelona & Charleroi. |
2019-03-12 |
| SOM Biotech S.L.. (3/7/19). "Press Release: SOM Biotech Closes a Financing Round of 7m Euros". Barcelona. |
2019-03-07 |
| Algenex S.L.. (3/5/19). "Press Release: Algenex Closes Funding Round and Strengthens Team with Key Senior Manager Appointments". Madrid. |
2019-03-05 |
| Grifols S.A.. (2/7/19). "Press Release: Grifols Receives FDA Approval for Procleix Babesia Assay for Donor Screening on Procleix Panther System". Barcelona. |
2019-02-07 |
| Grifols S.A.. (1/23/19). "Press Release: Grifols Announces Collaboration and License Agreement with Rigel Pharmaceuticals to Commercialize Fostamatinib in Europe". Barcelona. |
2019-01-23 |
| Life Biosciences LLC. (1/9/19). "Press Release: Senolytic Therapeutics Kicks Off Q1 2019 with High-profile Speaking Events Featuring Co-founders Marc Ramis and Manuel Serrano". Boston, MA. |
2019-01-09 |
| Bruker Corporation. (12/13/18). "Press Release: Bruker and Mestrelab Announce Strategic Collaboration and Partnership for Chemistry and Pharma Software Applications". Billerica, MA. |
2018-12-13 |
| Minoryx Therapeutics S.L.. (12/13/18). "Press Release: Minoryx Therapeutics Announces Early Completion of Patient Randomization in the ADVANCE Trial – a Phase 2/3 Clinical Study of MIN-102 in X-ALD Patients". Mataró, Barcelona. |
2018-12-13 |
| [iito] Business Intelligence. (10/31/18). "Press Release: [iito] Discontinues Life-Sciences-Spain.com. All Data Will Still Be Available at Life-Sciences-Europe.com". Bremen. |
2018-10-31 |
| Galecto Biotech AB. (10/26/18). "Press Release: Galecto Biotech Raises €79 Million in Series C Financing Co-Led by Ysios Capital and OrbiMed to Advance Galectin Inhibitor to Late-Stage Clinical Development". Copenhagen. |
2018-10-26 |
| Oryzon Genomics S.A.. (10/26/18). "Press Release: Oryzon Raises EUR 13 Million through a Private Placement with US and European Investors [Not for US, CA, AU, JP, ZA or any other jurisdiction where unlawful]". Madrid & Cambridge, MA. |
2018-10-26 |
| Aelix Therapeutics S.L.. (10/18/18). "Press Release: Aelix Therapeutics and Gilead Sciences Enter into a Clinical Research Collaboration Agreement to Evaluate a Therapeutic Vaccine and TLR7 Agonist Regimen for HIV Cure". |
2018-10-18 |
| Minoryx Therapeutics S.L.. (9/26/18). "Press Release: Minoryx Therapeutics Raises €21.3M in Series B Funding Round". Mataró, Barcelona. |
2018-09-26 |
| Ysios Capital. (9/24/18). "Press Release: Ysios Capital Strengthens Its Team with the Appointment of Guillem Laporta as Principal and Two New Venture Partners". Barcelona. |
2018-09-24 |
| Minoryx Therapeutics S.L.. (9/21/18). "Press Release: A Consortium Led by Minoryx Receives €0.8m to Explore Additional Indications for MIN-102". |
2018-09-21 |
| Evotec AG. (9/17/18). "Press Release: Evotec and Almirall Enter into Research Collaboration in the Field of Dermatiological Diseases". Hamburg & Barcelona. |
2018-09-17 |
| European Invesmtent Bank (EIB). (9/7/18). "Press Release: Investment Plan for Europe – the EIB and Grifols Sign a New Loan Agreement to Advance Research on Rare and Chronic Diseases". |
2018-09-07 |
| Devicare S.L.. (9/6/18). "Press Release: Devicare Gets the Patent for Its Sensor Technology in Europe and USA". |
2018-09-06 |
| Minoryx Therapeutics S.L.. (9/5/18). "Press Release: Minoryx Therapeutics Announces Dosing of First US Patient in Phase 2/3 Clinical study of MIN-102 (ADVANCE)". Mataró, Barcelona. |
2018-09-05 |
| Mologen AG. (8/1/18). "Press Release: Dr Ignacio Faus Appointed as New CEO of Mologen AG". Berlin. |
2018-08-01 |
| Eurofins Scientific. (7/27/18). "Press Release: Eurofins Becomes the Market Leader in Food Testing Services in Spain with the Acquisition of Ecosur". |
2018-07-27 |
| Grifols S.A.. (7/27/18). "Press Release: First Half 2018 Results. Grifols Increases Net Profits by 15% to EUR 319 Million, with Sustained Operational Revenue Growth of 7%". Barcelona. |
2018-07-27 |
| Locust Walk Partners, LLC. (7/11/18). "Press Release: Locust Walk Appoints Lubor Gaal as Senior Vice President and Head of Europe to Further Advance Global Expansion of Transactions Business". London & Boston, MA. |
2018-07-11 |
| Nordic Nanovector ASA. (6/25/18). "Press Release: Nordic Nanovector Appoints Eduardo Bravo as Chief Executive Officer". Oslo. |
2018-06-25 |
| Lunaphore Technologies S.A.. (5/24/18). "Press Release: Lunaphore and Vitro Sign Collaboration Agreement to Develop ISH Protocols for RNA/DNA Targets". Lausanne & Seville. |
2018-05-24 |
| Bionure. (5/16/18). "Press Release: Bionure Initiates a Phase 1 Clinical Trial of Its Lead Compound BN201 in the United Kingdom". Barcelona. |
2018-05-16 |
| Applied Photophysics Ltd.. (5/15/18). "Press Release: Applied Photophysics Signs Agreements with Alfatest and Paralab to Expand Distribution in Europe". Surrey, Rome & Valborn. |
2018-05-15 |
| Oryzon Genomics S.A.. (5/14/18). "Press Release: Oryzon Announces First Patients In ETHERAL – a Phase IIa Clinical Trial in Alzheimer’s Disease with ORY-2001". Madrid & Cambridge, MA. |
2018-05-14 |
| Grifols S.A.. (5/10/18). "Press Release: Grifols Reaches an Agreement with Boya Bio-Pharmaceutical to Open Plasma Collection Centers in China". Barcelona. |
2018-05-10 |
| Phenomenex, Inc.. (5/2/18). "Press Release: Phenomenex Expands International Network with Direct Sales to Portugal". Torrance, CA. |
2018-05-02 |
| Bruker Corporation. (4/20/18). "Press Release: Bruker Introduces Bologna Workflow for Rapid and Cost-Effective Clinical Microbiology Diagnosis of Bloodstream Infections with Broad Species Coverage". Madrid. |
2018-04-20 |
| Qiagen N.V.. (4/19/18). "Press Release: Qiagen Announces European Launch of QIAstat-Dx, a Next Generation Platform for Syndromic Insights". Hilden & Germantown, MD. |
2018-04-19 |
| Curetis N.V.. (4/19/18). "Press Release: Curetis Launches CE-IVD Marked Unyvero Urinary Tract Infection (UTI) Cartridge at ECCMID 2018". Amsterdam, San Diego, CA & Holzgerlingen. |
2018-04-19 |
| Curetis N.V.. (4/18/18). "Press Release: Curetis – Novel Products and Study Data to Be Presented at ECCMID 2018". Amsterdam, San Diego, CA & Holzgerlingen. |
2018-04-18 |
| Oncgnostics GmbH. (4/16/18). "Press Release: Test for Uterine Cancer in Portugal. Biotech Firm Oncgnostics Grants Exclusive Licence for Cancer Screening Test". Lisbon & Jena. |
2018-04-16 |
| LeanBio S.L.. (3/23/18). "Press Release: Syna Therapeutics, the New Joint Venture between LeanBio S.L. and Laboratoris Reig I Jofre". |
2018-03-23 |
| Mestrelab Research S.L.. (3/21/18). "Press Release: Mestrelab Research Response to ACDLabs Press Release about Lawsuit for Copyright Infringement". |
2018-03-21 |
| Advanced Chemistry Development, Inc. (ACD/Labs). (3/20/18). "Press Release: ACD/Labs Files Lawsuit for Copyright Infringement against MestreLab Research". Toronto. |
2018-03-20 |
| Grifols S.A.. (3/20/18). "Press Release: Grifols Expands and Diversifies Its Plasma Collection Network with the Acquisition of 35 Donation Centers in Germany from Aton". Barcelona. |
2018-03-20 |
| Laboratoris Sanifit S.L.. (3/6/18). "Press Release: Sanifit Announces Results of the Phase II Clinical Trial of SNF472 in Patients with Calciphylaxis". Palma & San Diego, CA. |
2018-03-06 |
| Grifols S.A.. (2/28/18). "Press Release: Grifols Revenues Exceed EUR 4,300 Million and Reported Profit Reaches EUR 663 Million". Barcelona. |
2018-02-28 |
| Minoryx Therapeutics S.L.. (2/20/18). "Press Release: Minoryx Therapeutics Spins Off SEE-Tx Platform into New Company, Gain Therapeutics". Mataró, Barcelona & Lugano. |
2018-02-20 |
| ABAC Therapeutics. (2/15/18). "Press Release: ABAC Therapeutics Announces €16 Million Series A to Develop Therapeutic Solutions to Fight Antibiotic-resistant Bacteria". Barcelona. |
2018-02-15 |
| PharmaMar S.A.. (2/14/18). "Press Release: PharmaMar Licenses Fully Synthetic Marine-derived Payloads to Seattle Genetics for Use in Drug Conjugates". Madrid. |
2018-02-14 |
| Qiagen N.V.. (1/31/18). "Press Release: Qiagen Enters into Agreement to Acquire STAT-Dx, Plans to Launch a Next-generation, Fully Integrated Multiplex Platform for Syndromic Disease Testing". Germantown, MD & Hilden. |
2018-01-31 |
| Lipopharma Therapeutics S.L.. (1/21/18). "Press Release: Lipopharma Awarded a 6.15m€ Grant by the H2020 Programme to Conduct a PIIb Trial with 2OHOA in Patients with Newly-diagnosed Glioblastoma". Palma de Mallorca & Acton, MA. |
2018-01-21 |
| Genomica SAU. (1/18/18). "Press Release: Genomica Opens Its First Subsidiary in China". Madrid. |
2018-01-18 |
| GoodGut. (1/18/18). "Press Release: GoodGut Does Trials on More Effective Test to Prevent Colon Cancer". Girona. |
2018-01-18 |
| PharmaMar S.A.. (1/18/18). "Press Release: Pharma Mar, S.A. Announces the Results of the Phase III Clinical Trial (CORAIL) with Zepsyre (lurbinectedin) in Platinum-resistant Ovarian Cancer patients". Colmenar Viejo (Madrid). |
2018-01-18 |
| Mind the Byte S.L.. (1/11/18). "Press Release: Mind the Byte Acquires Intelligent Pharma". |
2018-01-11 |
| Laboratoris Sanifit S.L.. (1/8/18). "Press Release: Sanifit Announces the Appointment of Cris Calsada as Chief Financial Officer". Palma & San Diego, CA. |
2018-01-08 |
| Abivax S.A.. (12/7/17). "Press Release: Abivax to Present in Plenary Session at the 8th International Conference on HIV Persistence during Therapy". Paris. |
2017-12-07 |
| Grifols S.A.. (11/17/17). "Press Release: FDA Approval of Genetic Test for Alpha-1 Deficiency and EMA Approval of Fibrin Sealant". Barcelona. |
2017-11-17 |
| Xeltis AG. (11/15/17). "Press Release: Xeltis Closes €45 Million in Oversubscribed Series C Financing to Advance Aortic and Pulmonary Valve Programs". Zurich & Eindhoven. |
2017-11-15 |
| Mind the Byte S.L.. (11/15/17). "Press Release: Mind the Byte and Prosilico Sign a Strategic Partnership Agreement". |
2017-11-15 |
| Aelix Therapeutics S.L.. (10/20/17). "Press Release: Aelix Therapeutics Appoints Dr. Thomas Hecht as Chairman of the Board of Directors". |
2017-10-20 |
| Oryzon Genomics S.A.. (10/3/17). "Press Release: Significant Fact [Company Moves Registered Address from Barcelona to Madrid]". Madrid. |
2017-10-03 |
| Allergy Therapeutics plc. (9/28/17). "Press Release: Preliminary Results". |
2017-09-28 |
| Abivax S.A.. (9/18/17). "Press Release: First Patient Dosed in Three-month Cohort of Phase 2A Study of Oral ABX464 in HIV-supressed Patients". Paris. |
2017-09-18 |
| Ability Pharmaceuticals S.L.. (9/18/17). "Press Release: Ability Pharmaceuticals Announces EMA-Orphan Drug Designation for ABTL0812 in Pancreatic Cancer". Barcelona. |
2017-09-18 |
| Aelix Therapeutics S.L.. (9/5/17). "Press Release: Aelix Therapeutics Enrolls First Patient in Company’s Initial Therapeutic HIV Vaccine Clinical Trial". |
2017-09-05 |
| Merck KGaA. (8/31/17). "Press Release: Driving Innovation in Cancer Care at ESMO 2017 with New Data in Hard-to-Treat Cancers [Not intended for U.K. or U.S. based media]". Darmstadt. |
2017-08-31 |
| Almirall S.A.. (8/28/17). "Press Release: Almirall Appoints Peter Guenter as New CEO". Barcelona. |
2017-08-28 |
| Amcure GmbH. (8/23/17). "Press Release: Amcure Announces Formation of Inaugural Scientific Advisory Board". Eggenstein-Leopoldshafen. |
2017-08-23 |
| SpectralWorks Ltd.. (8/15/17). "Press Release: SpectralWorks and Mestrelab Research SL Announce Mutual Reseller Agreement". |
2017-08-15 |
| Grifols S.A.. (7/28/17). "Press Release: Grifols Increases Its Revenues by 12.3% to EUR 2,192 Million Driven by Growth of Its Main Divisions". Barcelona. |
2017-07-28 |
| Oryzon Genomics S.A.. (7/20/17). "Press Release: Oryzon to Regain Rights to ORY-1001 (RG6016)". Barcelona & Cambridge, MA. |
2017-07-20 |
| Mind the Byte S.L.. (7/10/17). "Press Release: Mind the Byte Raises 300,000 Euros in Its Second Equity Crowdfunding". |
2017-07-10 |
| Grifols S.A.. (7/5/17). "Press Release: Grifols Strengthens Its R&D+i through Investee Companies. Grifols Opens New Lines of Research with the Acquisition of a 44% Stake in GigaGen for USD 35 Million". Barcelona. |
2017-07-05 |
| Cellnovo. (6/29/17). "Press Release: Cellnovo Expands International Distribution Network". Paris. |
2017-06-29 |
| Invent Farma Holding Spain S.L.. (6/21/17). "Press Release: Invent Farma / Neuraxpharm Group Announces the Acquisition of FB Health in Italy". Barcelona & Düsseldorf. |
2017-06-21 |
| Oryzon Genomics S.A.. (5/31/17). "Press Release: Oryzon Genomics to Participate in a Panel at the JMP Securities Life Sciences Conference and Present at the Jefferies 2017 Global Health Conference". Barcelona & Cambridge, MA. |
2017-05-31 |
| PharmaMar S.A.. (5/18/17). "Press Release: PharmaMar Announces New Data with Its Compounds Yondelis and Lurbinectedin during ASCO 2017". Madrid. |
2017-05-18 |
| AptaTargets. (5/17/17). "Press Release: AptaTargets Closes €2.7 Million Round of Funding for New Stroke Treatment". Madrid. |
2017-05-17 |
| PharmaMar S.A.. (5/17/17). "Press Release: PharmaMar and Specialised Therapeutics Asia Sign Licensing and Marketing Agreement for Lurbinectedin Covering Australia, New Zealand and Several Asian Countries". Madrid. |
2017-05-17 |
| Oryzon Genomics S.A.. (5/16/17). "Press Release: Oryzon Announces Appointment of New Chief Medical Officer and Expansion of Its Medical Department". Barcelona & Cambridge, MA. |
2017-05-16 |
| Mind the Byte S.L.. (5/9/17). "Press Release: Mind the Byte Launches a New Equity Crowdfunding Campaign with Crowdcube". |
2017-05-09 |
| PharmaMar S.A.. (5/4/17). "Press Release: Aplidin Receives Orphan Drug Status for the Treatment of Multiple Myeloma in Switzerland". Madrid. |
2017-05-04 |
| Abivax S.A.. (5/2/17). "Press Release: First Ever Evidence of Treatment-induced Reduction in HIV Reservoirs". Paris. |
2017-05-02 |
| Oryzon Genomics S.A.. (3/31/17). "Press Release: Oryzon Raises €18 Million through a Private Placement with US and European Investors [Not for US, CA, AU, JP, ZA, et al.]". Barcelona. |
2017-03-31 |
| Neovacs S.A.. (3/30/17). "Press Release: Neovacs Provides Corporate Update and Reports Full Year 2016 Financial Results". Paris. |
2017-03-30 |
| BioClin Therapeutics, Inc.. (3/22/17). "Press Release: BioClin Therapeutics, Inc., Raises $30 Million in Series B Financing Led by Sofinnova Ventures and Ysios Capital". San Ramon, CA. |
2017-03-22 |
| Medivir AB. (3/16/17). "Press Release: Medivir Completes Transition of Commercial Products to Fully Focus on Research and Development". Stockholm. |
2017-03-16 |
| Alimera Sciences, Inc.. (3/13/17). "Press Release: Alimera Sciences Signs Agreement for Exclusive Distributor of Iluvien in Spain". Atlanta, GA. |
2017-03-13 |
| Oryzon Genomics S.A.. (2/27/17). "Press Release: Oryzon Presented New Preclinical Data of ORY-2001 Therapeutic Activity in Multiple Sclerosis at ACTRIMS-2017". Barcelona & Cambridge, MA. |
2017-02-27 |
![[LSE] Life-Sciences-Europe.com - The European Life Sciences Web Portal](/images/basics/lse-life-sciences-europe-portal-logo-2019.png){kind=logo}
![Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px](/banner/iito-20190621-650-089-life-sciences-asia.jpg)
Date
![Picture [iito] LSUS iitoLifeScience Transatlantic Life Sciences 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
